Caris Life Sciences, Inc. , an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Caris Life Sciences stock last closed at $18.41, down 2.13% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Diagnostics & Research industry by N/A percentage points. Caris Life Sciences stock is currently +7.35% from its 52-week low of $17.15, and -56.68% from its 52-week high of $42.50.
At the moment, there are 282.58M CAI shares outstanding. The market cap of CAI is $5.20B. In the last 24 hours, 8.27M CAI shares were traded.
How to Buy Caris Life Sciences Stock
Not sure how to invest in Caris Life Sciences stock? Here's how.
Decide where to buy Caris Life Sciences stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Caris Life Sciences stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Select your method of payment and add your details.
Evaluate Caris Life Sciences stock: The Caris Life Sciences ticker symbol is CAI. Is Caris Life Sciences stock a good investment? Should you buy shares of CAI? How do CAI's underlying business fundamentals look? Do top analysts think Caris Life Sciences is a good buy? Why has CAI's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if CAI is a good stock to buy).
Make your CAI trade: Decide if you will purchase CAI shares at the current market price or use a limit order to purchase CAI stock at a particular price.
Keep tabs on your CAI position: Create a watchlist to important updates regarding your investment in Caris Life Sciences shares.
Step 1: Decide where to buy Caris Life Sciences stock
You need a brokerage account to access the NASDAQ market and buy CAI stock.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to buy CAI today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Caris Life Sciences stock
Once you have figured out the best place to buy Caris Life Sciences stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk as well as the upside.
Caris Life Sciences Metrics
CAI Price
$18.41
1w %
1.43%
1y %
N/A
5y %
N/A
P/E
-5.72x
P/B
9.01x
P/S
3.79x
PEG
N/A
Revenue
$812.03M
Earnings
-$537.96M
Fore. Rev. Growth
21.61%
Fore. Earn. Growth
N/A
Market Cap
$5.20B
Next Earnings
N/A
Next Dividend
N/A
Fundamentals of CAI
WallStreetZen was created to help everyday investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on CAI's stock page.
Is CAI stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge CAI's fair value.
Using relative valuations ratios:
CAI could be overvalued based on its P/B ratio of 9.01x, relative to Diagnostics & Research industry P/B ratio of 3.64x
Last year, CAI revenue was $812.03M. In the last 2 year, CAI's revenue has gone up by 62.87% per year. This was faster than the Diagnostics & Research industry average of 9.47%.
No, Caris Life Sciences doesn't provide an income stream by paying out dividends.
CAI Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CAI trade
You have two main options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly the easiest way to buy.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific price, use a limit order.
Click the Open button and eToro will place the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Caris Life Sciences share?
As of Mar 20, 2026, it costs $18.41 to buy one share of Caris Life Sciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.489 shares of CAI.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.